Global Blood Therapeutics

Forma Therapeutics

This company develops medicines for patients with sickle cell disease and rare blood disorders.

Bluebird Bio

This company develops and manufactures gene therapies for patients with severe genetic diseases, including sickle cell disease and beta-thalassaemia.

Imara

This biopharmaceutical company develops oral small-molecule therapies to treat patients with rare genetic blood disorders, including sickle cell disease and beta thalassemia.

Actelion

This company develops and manufactures pharmaceutical drugs to treat orphan diseases such as pulmonary arterial hypertension for patients and healthcare providers globally.

Forma

This company develops small molecule therapies for patients with sickle cell disease and cancer.

IMMvention Therapeutics

This biotechnology firm develops small molecule oral therapies for patients with sickle cell disease and other inflammatory or neurodegenerative conditions.

Genetix Biotherapeutics

The company develops and commercialises gene therapies for patients suffering from severe rare genetic disorders such as sickle cell disease and beta thalassemia.

Gossamer Bio

This biopharmaceutical company develops inhaled therapies for patients suffering from pulmonary arterial hypertension and interstitial lung disease.